Home › ETF database › XLV
XLV Health Care Select Sector SPDR Fund
XLV is a Healthcare ETF issued by State Street. It tracks the S&P 500 Health Care index, costs 0.12% a year, and launched in December 1998.
Composition last reviewed 2026-09-08; assets as of 2026-09-24.
Key facts
| Ticker | XLV |
|---|---|
| Full name | Health Care Select Sector SPDR Fund |
| Issuer | State Street |
| Category | Healthcare |
| Sub-category | S&P Sector |
| Index tracked | S&P 500 Health Care |
| Expense ratio | 0.12% |
| Assets under management | $42.81bn |
| Inception | 22 December 1998 |
| Asset class | Equity |
| Region | US |
Sector allocation
- Healthcare100%
Geographic exposure
United States vs international
- United States98%
- International (ex-US)2%
Top 10 holdings
- 1UnitedHealth
- 2Johnson & Johnson
- 3Pfizer
- 4Eli Lilly
- 5Merck
- 6AbbVie
- 7Bristol Myers Squibb
- 8Amgen
- 9Gilead Sciences
- 10Biogen
Frequently asked
What is XLV's expense ratio?
Health Care Select Sector SPDR Fund charges 0.12% a year — $12 on a $10,000 holding.
What index does XLV track?
Health Care Select Sector SPDR Fund tracks the S&P 500 Health Care index.
How large is XLV?
Our dataset puts XLV at about $42.81bn in assets under management (as of 2026-09-24). Assets move with markets and flows, so treat this as a snapshot rather than a current figure.
What are XLV's largest holdings?
The 10 largest holdings in our dataset are UnitedHealth, Johnson & Johnson, Pfizer, Eli Lilly, Merck, AbbVie, Bristol Myers Squibb, Amgen, Gilead Sciences and Biogen.
Where is XLV invested?
Roughly 98% of the fund sits in the United States and 2% outside it.